ASO Author Reflections: Lessons Learned from Neoadjuvant Endocrine Therapy use for Estrogen Receptor Positive Breast Cancer during the Covid-19 Pandemic.
0/5 보강
APA
Douglas SR, van den Bruele AMB, Chiba A (2026). ASO Author Reflections: Lessons Learned from Neoadjuvant Endocrine Therapy use for Estrogen Receptor Positive Breast Cancer during the Covid-19 Pandemic.. Annals of surgical oncology, 33(1), 161-162. https://doi.org/10.1245/s10434-025-18380-9
MLA
Douglas SR, et al.. "ASO Author Reflections: Lessons Learned from Neoadjuvant Endocrine Therapy use for Estrogen Receptor Positive Breast Cancer during the Covid-19 Pandemic.." Annals of surgical oncology, vol. 33, no. 1, 2026, pp. 161-162.
PMID
40987988 ↗
같은 제1저자의 인용 많은 논문 (5)
- Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
- Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.
- ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
- ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic.
- ASO Author Reflections: Moving Toward Evidence-Based Guidelines for Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.